Target Interacting Protein Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T58470 | Target Info | |||
Target Name | Cyclin A2 (CCNA2) | ||||
Synonyms | Cyclin-A2; Cyclin-A; Cyclin A; CCNA | ||||
Target Type | Literature-reported Target | ||||
Gene Name | CCNA2 | ||||
UniProt ID |
Target Interacting Proteins | Top | ||||
---|---|---|---|---|---|
Beta-transducin repeats | [+] 2 Beta-transducin repeats | + | |||
Interacting Protein Name | Cell division cycle protein 20 homolog (CDC20) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CDC20A; bA276H19.3; p55CDC | ||||
Evidence Score (E-score) | 9 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Affinity Capture-Western | [3] | |||
4 | Affinity Capture-Western | [4] | |||
5 | Affinity Capture-Western | [5] | |||
6 | Affinity Capture-Western | [6] | |||
7 | Protein-peptide | [4] | |||
8 | Reconstituted Complex | [6] | |||
9 | Reconstituted Complex | [3] | |||
Interacting Protein Name | Fizzy-related protein homolog (FZR1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CDC20C; CDH1; FZR; FZR2; HCDH; HCDH1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [6] | |||
3 | Reconstituted Complex | [6] | |||
Cell division cycle proteins | [+] 1 Cell division cycle proteins | + | |||
Interacting Protein Name | Retinoblastoma-like protein 1 (RBL1) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CP107; PRB1; p107 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-MS | [1] | |||
3 | Affinity Capture-Western | [8] | |||
4 | Affinity Capture-Western | [9] | |||
Histones | [+] 1 Histones | + | |||
Interacting Protein Name | Histone H1.1 (HIST1H1A) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | H1.1; H1A; H1F1; HIST1 | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [10] | |||
2 | Biochemical Activity | [11] | |||
3 | Biochemical Activity | [12] | |||
4 | Biochemical Activity | [13] | |||
5 | Biochemical Activity | [14] | |||
6 | Biochemical Activity | [15] | |||
7 | Biochemical Activity | [16] | |||
Kinases | [+] 3 Kinases | + | |||
Interacting Target Name | Cyclin-dependent kinase 2 (CDK2) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | SIN3-associated protein; Sin3 associated polypeptide; P33 protein kinase; Cell division protein kinase 2; CDKN2 | ||||
Evidence Score (E-score) | 17 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [2] | |||
2 | Affinity Capture-Western | [17] | |||
3 | Affinity Capture-Western | [4] | |||
4 | Affinity Capture-Western | [18] | |||
5 | Affinity Capture-Western | [3] | |||
6 | Affinity Capture-Western | [5] | |||
7 | Affinity Capture-Western | [6] | |||
8 | Affinity Capture-Western | [19] | |||
9 | Affinity Capture-Western | [20] | |||
10 | Affinity Capture-Western | [9] | |||
11 | Affinity Capture-Western | [21] | |||
12 | Affinity Capture-Western | [22] | |||
13 | Affinity Capture-Western | [13] | |||
14 | Affinity Capture-Western | [23] | |||
15 | Co-crystal Structure | [24] | |||
16 | Reconstituted Complex | [25] | |||
17 | Reconstituted Complex | [26] | |||
Interacting Target Name | Cyclin-dependent kinase 1 (CDK1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P34CDC2; P34 protein kinase; CDKN1; CDC28A; CDC2 | ||||
Evidence Score (E-score) | 10 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-MS | [1] | |||
3 | Affinity Capture-MS | [2] | |||
4 | Affinity Capture-Western | [17] | |||
5 | Affinity Capture-Western | [6] | |||
6 | Affinity Capture-Western | [27] | |||
7 | Affinity Capture-Western | [12] | |||
8 | Affinity Capture-Western | [28] | |||
9 | Affinity Capture-Western | [19] | |||
10 | Affinity Capture-Western | [20] | |||
Interacting Target Name | Cyclin-dependent kinase 7 (CDK7) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TFIIH basal transcription factor complex kinase subunit; Serine/threonine-protein kinase 1; P39 Mo15; MO15; Cell division protein kinase 7; CDKN7; CDK-activating kinase 1; CDK-activating kinase; CAK1; CAK; 39 kDa protein kinase | ||||
Evidence Score (E-score) | 2 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [29] | |||
2 | Biochemical Activity | [30] | |||
Transcription regulators | [+] 1 Transcription regulators | + | |||
Interacting Target Name | Transcription factor Sp1 (SP1) | Clinical trial Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | TSFP1 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-Western | [31] | |||
2 | Reconstituted Complex | [32] | |||
3 | Reconstituted Complex | [31] | |||
Other proteins | [+] 6 Other proteins | + | |||
Interacting Target Name | Melanoma differentiation-associated protein 6 (CDKN1A) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | WAF1; SDI1; PIC1; P21(WAF1); P21; Melanoma differentiation associated protein 6; MDA-6; MDA6; Cyclin-dependent kinase inhibitor 1; CIP1; CDK-interacting protein 1; CAP20 | ||||
Evidence Score (E-score) | 8 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-MS | [1] | |||
3 | Affinity Capture-Western | [33] | |||
4 | Affinity Capture-Western | [18] | |||
5 | Affinity Capture-Western | [27] | |||
6 | Affinity Capture-Western | [28] | |||
7 | Affinity Capture-Western | [14] | |||
8 | Reconstituted Complex | [34] | |||
Interacting Target Name | CDK inhibitor 1B p27Kip1 (CDKN1B) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | p27Kip1; KIP1; Cyclin-dependent kinase inhibitor p27; Cyclindependent kinase inhibitor p27; Cyclin-dependent kinase inhibitor 1B | ||||
Evidence Score (E-score) | 7 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-MS | [1] | |||
3 | Affinity Capture-MS | [2] | |||
4 | Affinity Capture-Western | [33] | |||
5 | Affinity Capture-Western | [18] | |||
6 | Affinity Capture-Western | [21] | |||
7 | Affinity Capture-Western | [35] | |||
Interacting Target Name | S-phase kinase-associated protein 2 (SKP2) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | Skp2; P45skp2; FBXL1; F-box/LRR-repeat protein 1; F-box protein Skp2; Cyclin-A/CDK2-associated protein p45; Cyclin A/CDK2-associated protein p45; Cyclin A/CDK2-associated p45 | ||||
Evidence Score (E-score) | 5 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-MS | [1] | |||
3 | Affinity Capture-MS | [2] | |||
4 | Affinity Capture-Western | [35] | |||
5 | Affinity Capture-Western | [36] | |||
Interacting Target Name | CDK inhibitor 1C p57Kip2 (CDKN1C) | Literature-reported Target | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | P57KIP2; P57(KIP2); KIP2; Cyclin-dependent kinase inhibitor p57; Cyclin-dependent kinase inhibitor 1C | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [7] | |||
2 | Affinity Capture-MS | [1] | |||
3 | Affinity Capture-MS | [2] | |||
4 | Affinity Capture-Western | [33] | |||
Interacting Protein Name | Cyclin-dependent kinases regulatory subunit 1 (CKS1B) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CKS1; PNAS.16; PNAS.18; ckshs1 | ||||
Evidence Score (E-score) | 4 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-MS | [2] | |||
3 | Affinity Capture-Western | [5] | |||
4 | Affinity Capture-Western | [6] | |||
Interacting Protein Name | Cyclin-dependent kinases regulatory subunit 2 (CKS2) | Interacting Protein | Interacting Protein Info | ||
UniProt ID | |||||
Synonyms | CKSHS2 | ||||
Evidence Score (E-score) | 3 Experimental Evidences | + | |||
1 | Affinity Capture-MS | [1] | |||
2 | Affinity Capture-Western | [5] | |||
3 | Affinity Capture-Western | [6] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell. 2015 Jul 16;162(2):425-440. | ||||
REF 2 | A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell. 2015 Oct 22;163(3):712-23. | ||||
REF 3 | How cyclin A destruction escapes the spindle assembly checkpoint. J Cell Biol. 2010 Aug 23;190(4):501-9. | ||||
REF 4 | The ABBA motif binds APC/C activators and is shared by APC/C substrates and regulators. Dev Cell. 2015 Feb 9;32(3):358-372. | ||||
REF 5 | Cdc20 and Cks direct the spindle checkpoint-independent destruction of cyclin A. Mol Cell. 2008 May 9;30(3):290-302. | ||||
REF 6 | Degradation of cyclin A is regulated by acetylation. Oncogene. 2009 Jul 23;28(29):2654-66. | ||||
REF 7 | Architecture of the human interactome defines protein communities and disease networks. Nature. 2017 May 25;545(7655):505-509. | ||||
REF 8 | B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107. Oncogene. 2002 Nov 14;21(52):7923-32. | ||||
REF 9 | Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A. Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10453-8. | ||||
REF 10 | A p27Kip1 mutant that does not inhibit CDK activity promotes centrosome amplification and micronucleation. Oncogene. 2012 Aug 30;31(35):3989-98. | ||||
REF 11 | PRC1: a human mitotic spindle-associated CDK substrate protein required for cytokinesis. Mol Cell. 1998 Dec;2(6):877-85. | ||||
REF 12 | The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity. Oncogene. 1997 Jan 30;14(4):491-8. | ||||
REF 13 | Altered p27(Kip1) phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor beta-mediated G(1) arrest. Mol Cell Biol. 2002 May;22(9):2993-3002. | ||||
REF 14 | Modulation of cell cycle control by vitamin D3 and its analogue, EB1089, in human breast cancer cells. Oncogene. 1997 Sep 25;15(13):1555-63. | ||||
REF 15 | Cyclin-dependent kinase-2 (Cdk2) forms an inactive complex with cyclin D1 since Cdk2 associated with cyclin D1 is not phosphorylated by Cdk7-cyclin-H. Eur J Biochem. 1996 Apr 15;237(2):460-7. | ||||
REF 16 | p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function. Cancer Lett. 2009 Dec 28;286(2):240-9. | ||||
REF 17 | Phosphorylation of human Fen1 by cyclin-dependent kinase modulates its role in replication fork regulation. Oncogene. 2003 Jul 10;22(28):4301-13. | ||||
REF 18 | Cleavage of p21Cip1/Waf1 and p27Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: role of a caspase cascade. Mol Cell. 1998 Mar;1(4):553-63. | ||||
REF 19 | G2 delay induced by nitrogen mustard in human cells affects cyclin A/cdk2 and cyclin B1/cdc2-kinase complexes differently. J Biol Chem. 1993 Apr 15;268(11):8298-308. | ||||
REF 20 | APOLLON protein promotes early mitotic CYCLIN A degradation independent of the spindle assembly checkpoint. J Biol Chem. 2014 Feb 7;289(6):3457-67. | ||||
REF 21 | Differential modulation of G1-S-phase cyclin-dependent kinase 2/cyclin complexes occurs during the acquisition of a polyploid DNA content. Cell Growth Differ. 1998 Aug;9(8):639-50. | ||||
REF 22 | Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3521-4. | ||||
REF 23 | Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage. J Biol Chem. 1996 May 31;271(22):13283-91. | ||||
REF 24 | Mechanism of CDK activation revealed by the structure of a cyclinA-CDK2 complex. Nature. 1995 Jul 27;376(6538):313-20. | ||||
REF 25 | Cyclin G recruits PP2A to dephosphorylate Mdm2. Mol Cell. 2002 Apr;9(4):761-71. | ||||
REF 26 | Nuclear PTEN regulates the APC-CDH1 tumor-suppressive complex in a phosphatase-independent manner. Cell. 2011 Jan 21;144(2):187-99. | ||||
REF 27 | APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase. Mol Cell. 2007 Aug 3;27(3):462-73. | ||||
REF 28 | Destabilization of CARP mRNAs by aloe-emodin contributes to caspase-8-mediated p53-independent apoptosis of human carcinoma cells. J Cell Biochem. 2011 Apr;112(4):1176-91. | ||||
REF 29 | Dichotomous but stringent substrate selection by the dual-function Cdk7 complex revealed by chemical genetics. Nat Struct Mol Biol. 2006 Jan;13(1):55-62. | ||||
REF 30 | Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop. Mol Cell Biol. 2001 Jan;21(1):88-99. | ||||
REF 31 | Modulation of Sp1 activity by a cyclin A/CDK complex. J Mol Biol. 2001 Feb 16;306(2):201-12. | ||||
REF 32 | Cyclin A-CDK phosphorylates Sp1 and enhances Sp1-mediated transcription. EMBO J. 2001 Oct 15;20(20):5737-47. | ||||
REF 33 | The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain. J Biol Chem. 2003 Nov 7;278(45):44255-64. | ||||
REF 34 | Cyclin-binding motifs are essential for the function of p21CIP1. Mol Cell Biol. 1996 Sep;16(9):4673-82. | ||||
REF 35 | Melanoma antigen-A11 regulates substrate-specificity of Skp2-mediated protein degradation. Mol Cell Endocrinol. 2017 Jan 5;439:1-9. | ||||
REF 36 | p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase. Cell. 1995 Sep 22;82(6):915-25. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.